Brooklyn ImmunoTherapeutics Inc. (BTX) Social Stream

Brooklyn ImmunoTherapeutics Inc. (BTX): $0.59

0.05 (+8.93%)

POWR Rating

Component Grades













Add BTX to Watchlist
Sign Up

Industry: Biotech


of 400

in industry

Brooklyn ImmunoTherapeutics Inc (BTX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Brooklyn ImmunoTherapeutics Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-22 1 $20 $20 $20 $2.06 870.87%
2021-12-29 2 $20 $9 $14.5 $2.06 603.88%

BTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • BTX has a higher upside potential (average analyst target price relative to current price) than 294.64% of all US stocks.
  • Brooklyn ImmunoTherapeutics Inc's number of analysts covering the stock is greater than 9.38% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, Brooklyn ImmunoTherapeutics Inc's variance in analysts' estimates is lower than 15.13% of them.
  • In the context of Healthcare stocks, Brooklyn ImmunoTherapeutics Inc's average analyst price target is greater than 89.49% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Brooklyn ImmunoTherapeutics Inc are BTAI, BPTH, and BOLT.

Is BTX a Buy, Hold or Sell? See the POWR Ratings now!

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5219 seconds.